Storey RF - Search Results

1

Lowenstern A, Storey RF, Neely M, Sun JL, Angiolillo DJ, Cannon CP, Himmelmann A, Huber K, James SK, Katus HA, Morais J, Siegbahn A, Steg PG, Wallentin L, Becker RC; PLATO Investigators. Lowenstern A, et al. Among authors: storey rf. J Thromb Thrombolysis. 2017 Aug;44(2):145-153. doi: 10.1007/s11239-017-1516-y. J Thromb Thrombolysis. 2017. PMID: 28608165 Free PMC article. Clinical Trial.

2

Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes.

Storey RF, Oldroyd KG, Wilcox RG. Storey RF, et al. Thromb Haemost. 2001 Mar;85(3):401-7. Thromb Haemost. 2001. PMID: 11307804 Clinical Trial.

3

Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin.

Storey RF, Judge HM, Wilcox RG, Heptinstall S. Storey RF, et al. Thromb Haemost. 2002 Sep;88(3):488-94. Thromb Haemost. 2002. PMID: 12353080

4

Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.

Storey RF, May JA, Heptinstall S. Storey RF, et al. Thromb Res. 2005;115(4):301-7. doi: 10.1016/j.thromres.2004.09.004. Thromb Res. 2005. PMID: 15668190

5

Inhibitory effects of P2Y12 receptor antagonists on TRAP-induced platelet aggregation, procoagulant activity, microparticle formation and intracellular calcium responses in patients with acute coronary syndromes.

Behan MW, Fox SC, Heptinstall S, Storey RF. Behan MW, et al. Among authors: storey rf. Platelets. 2005 Mar;16(2):73-80. doi: 10.1080/09537100400005634. Platelets. 2005. PMID: 15823862 Free article.

6

PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.

Smith SM, Judge HM, Peters G, Armstrong M, Dupont A, Gaussem P, Storey RF. Smith SM, et al. Among authors: storey rf. Platelets. 2005 Sep;16(6):340-5. doi: 10.1080/00207230500120294. Platelets. 2005. PMID: 16194864 Free article.

7

Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses.

Judge HM, Buckland RJ, Holgate CE, Storey RF. Judge HM, et al. Among authors: storey rf. Platelets. 2005 Nov;16(7):398-407. doi: 10.1080/09537100500163226. Platelets. 2005. PMID: 16236601 Free article.

8

Biology and pharmacology of the platelet P2Y12 receptor.

Storey RF. Storey RF. Curr Pharm Des. 2006;12(10):1255-9. doi: 10.2174/138161206776361318. Curr Pharm Des. 2006. PMID: 16611109 Review.

9

Utility of a whole blood single platelet counting assay to monitor the effects of tirofiban in patients with acute coronary syndromes scheduled for coronary intervention.

Siotia A, Buckland R, Judge HM, Sastry P, Storey RF. Siotia A, et al. Among authors: storey rf. Thromb Haemost. 2006 Jun;95(6):997-1002. doi: 10.1160/TH05-08-0544. Thromb Haemost. 2006. PMID: 16732379 Clinical Trial.

10

Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial.

Cannon CP, Husted S, Harrington RA, Scirica BM, Emanuelsson H, Peters G, Storey RF; DISPERSE-2 Investigators. Cannon CP, et al. Among authors: storey rf. J Am Coll Cardiol. 2007 Nov 6;50(19):1844-51. doi: 10.1016/j.jacc.2007.07.053. Epub 2007 Oct 23. J Am Coll Cardiol. 2007. PMID: 17980250 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

413 results

Search Page

Filters